24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Patent
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:33
Full list of Israeli high-tech funding rounds in 2024
17:27
Eon rockets past $1 billion valuation in under a year, raising tens of millions more
14:56
Beyond bigger models: How AI’s next era will rethink growth
14:44
Israel ranks fourth globally for top universities per capita
More stories
Buzz
Most popular
Daily
Weekly
1
Eon rockets past $1 billion valuation in under a year, raising tens of millions more
2
Monday.com founders: “We have everything needed to get to $10 billion in revenue”
3
Israel’s next tech boom: Pioneering the future of global defensetech
4
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
5
Israel ranks fourth globally for top universities per capita
More news
Patent
2 stories about Patent
Teva’s Stock Drops After Approval of Copaxone Competitors
08.10.17
|
Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
Your First Investor Meeting, a Survival Guide
27.09.17
|
Zachi Zach
Your first meeting with a potential investor is critical because you probably won’t get another chance. Do your homework
Previous Articles
Please ensure Javascript is enabled for purposes of
website accessibility
